Previous 10 | Next 10 |
Current Chairman, Dr Alessandro Riva, MD, to become Chairman and Chief Executive Officer – Hedi Ben Brahim to retire as CEO. Decision made by AstraZeneca to terminate the oncolytic virus R&D collaboration. Transgene remains focused on its strategic priorities. Conference ca...
2023-05-02 16:17:51 ET Media mogul Byron Allen is interested in acquiring TV broadcast affiliates to add his holdings in the local broadcast networks. "We are very interested in any stations that become available, no matter who owns them," Allen said in an interview with Bloomberg TV, w...
TEGNA Inc. (NYSE: TGNA) today announced that KING, its NBC affiliate in Seattle, and journalist Chris Ingalls received The Brooks Jackson Prize for Fact-Checking, awarded by the Annenberg Public Policy Center in partnership with USC Annenberg’s Cronkite Awards, for The Fraud Crusade , ...
2023-04-21 11:15:00 ET Tegna ( NYSE: TGNA ) fell 3.1% after an appeals court declined to speed up a regulatory review of Standard General's $5.4 billion purchase of the TV broadcaster. The U.S. Court of Appeals for the District of Columbia Circuit rejected Standard General's...
- New Phase I data confirm promising immunogenicity and efficacy profile of TG4050, an individualized neoantigen cancer vaccine developed by Transgene in collaboration with NEC Corporation - In the head and neck cancer trial to date, all patients treated with TG4050 have remained disease-free...
2023-04-17 13:47:02 ET Tegna ( NYSE: TGNA ) rose 1.3% as Standard General disclosed some commitments it's pledged to the unions that have thus far not supported the $5.4 billion takeover of the broadcaster. Standard General said the additional pledges to the NewsGuild-CWA an...
Invir.IO® based oncolytic virus TG6050, is armed with IL-12 and an anti-CTLA4 antibody. A Phase I trial (Delivir) recently started enrolling patients with advanced non-small cell lung cancer (NSCLC) Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that design...
Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced that the Board of Directors has proposed Ms. Carol Stuckley, MBA, as an independent Director of the Company. This appointment re...
TEGNA Inc. (NYSE: TGNA) today announced that KARE in Minneapolis and KXTV in Sacramento have been nominated for Peabody Awards, which honor the most compelling and empowering stories released in broadcasting and streaming media during 2022. In the News category, KARE was nominated for KARE ...
Regulatory News: Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies , announced that the documentation related to the Combined General Meeting (ordinary and extraordinary sessions) of Transgene’s shareholders is ...
News, Short Squeeze, Breakout and More Instantly...
Strasbourg, France, and Lund, Sweden, July 22, 2024, 8:00 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and BioInvent International AB (“BioInvent”) (Nasdaq Stock...
Gray Media stations in Anchorage and Juneau will broadcast all locally available Seattle Kraken games, free over-the-air beginning with the 2024-2025 season TEGNA Inc. (NYSE: TGNA), the Seattle Kraken and Gray Media (NYSE: GTN) today announced that Gray’s KAUU in Anchorage and ...
NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) (“OLAPLEX” or “the Company”) today announced the appointment of two highly seasoned leaders to its executive team. Catherine Dunleavy will join OLAPLEX as Chief Operating Officer and Chie...